Mecoprax Injection is a parenteral formulation containing a combination of Methylcobalamin (1500 mcg), Nicotinamide (100 mg), and Pyridoxine Hydrochloride (100 mg), designed to address various neurological and metabolic deficiencies. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration, myelin sheath repair, and hematopoiesis, making it effective in treating peripheral neuropathies, diabetic neuropathy, and vitamin B12 deficiency. Nicotinamide, a form of vitamin B3, contributes to cellular metabolism, DNA repair, and exhibits neuroprotective properties, thereby supporting nerve function and energy production. Pyridoxine Hydrochloride (vitamin B6) is essential for amino acid metabolism, neurotransmitter synthesis, and immune function, aiding in the management of neuropathic pain and preventing vitamin B6 deficiency-related neurological disorders. Mecoprax Injection is indicated for the treatment of peripheral neuropathy, neuralgia, vitamin B complex deficiencies, and conditions requiring neurotrophic support. It is administered intramuscularly or intravenously under medical supervision, ensuring rapid bioavailability and therapeutic efficacy. Caution is advised in patients with hypersensitivity to any components, and dosage adjustments may be necessary in renal impairment. Mecoprax Injection should be used as part of a comprehensive treatment plan, with monitoring for potential adverse reactions such as injection site pain or allergic responses.